Business
PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany
PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n \n \n \n PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n The Company will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022.\n \n \n \n \n This is PharmaCielo's first sales agreement related to THC products. Represents a significant milestone related to management's re-focusing of PharmaCielo's product strategy toward THC-dominant products.\n \n \n \n \n \n TORONTO\n \n and RIONEGRO, Colombia,\n \n Feb. 14, 2022\n \n /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of\n \n Colombia's\n \n premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (\"Holdings\"), today announced that it had signed a sales agreement (the \"Agreement\") with Greenstein Germany GmbH (\"Greenstein\"), an independent pharmaceutical wholesaler specializing in the distribution of cannabis-based phytopharmaceuticals in\n \n Germany\n \n . Greenstein has a joint venture with NOWEDA e.G. (\"NOWEDA\"), a German pharmacist-owned cooperative founded in 1939 that supplies all pharmacies across\n \n Germany\n \n . Under the Agreement, PharmaCielo will initially supply NOWEDA via Greenstein three THC-dominant final products, with shipments expected to begin in late 2022. Additional details related to the Agreement were not disclosed.\n \n \n \n \n \n \n \n \n \n \n Management Commentary\n \n \n \n \n \n Bill Petron\n \n \n ,\n \n CEO of PharmaCielo\n \n , commented, \"Through its joint venture with NOWEDA, Greenstein has access to one of the largest pharmaceutical wholesale distribution networks in\n \n Germany\n \n . Between NOWEDA's reach, and the built-in scalability of PharmaCielo's operations, we see a substantial opportunity to build this relationship over the long-term to the...